Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Cannabidiol |
| Synonyms | |
| Therapy Description |
Cannabidiol is a cannabis derivative, which has been shown to interfere with proliferation, migration, and metastasis in cultured cells and xenograft models (PMID: 22506672, PMID: 32397428). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Cannabidiol | CBD|GWP42003-P|Epidiolex|GWP-42003 | Cannabidiol is a cannabis derivative, which has been shown to interfere with proliferation, migration, and metastasis in cultured cells and xenograft models (PMID: 22506672, PMID: 32397428). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04428203 | Phase I | Cannabidiol | Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | Completed | USA | 0 |
| NCT02332655 | Phase Ib/II | Cannabidiol | Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome | Completed | USA | 0 |